Cellid rises 8.65% amid immune checkpoint inhibitor theme uptrend
On the 10th, the immuno-oncology theme rose 3.09% compared to the previous day, showing strength, while Cellid, a related stock attracting attention, surged 8.65% compared to the previous day.
[Graph] Price Fluctuations of Major Immuno-Oncology Theme Stocks
According to provisional data compiled at 10:26, foreign investors are net buying 0.72 ten thousand shares of Cellid.
[Table] Net Trading Volume of Foreign and Institutional Investors (Unit: Ten Thousand Shares)
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
